Vaccination using peptides spanning the SYT-SSX tumor-specific translocation

Jordan E Bloom1, Douglas G McNeel, Brian M Olson

  • 1University of Wisconsin Carbone Cancer Center, 1111 Highland Avenue, Madison, WI 53705, USA.

Expert Review of Vaccines
|December 21, 2012
PubMed
Summary

This study evaluated a SYT-SSX breakpoint peptide vaccine for synovial sarcoma. The vaccine did not elicit a robust immune response, though some patients showed stable disease when treated with adjuvant and interferon-alpha.

Related Concept Videos